A History of Impact
Ferozsons Laboratories Limited was established in 1954 as one of the first Pharmaceutical manufacturing companies in Pakistan, and has now entered its seventh decade of serving the cause of health and well-being in Pakistan and a growing number of international markets.
The company has emerged as one of Pakistan’s fastest-growing pharmaceutical firms, recognized for delivering high-quality healthcare solutions and building leading brands across key therapeutic areas, including gastroenterology, hepatology, cardiology, and oncology.
2024
Ferozsons launches Sematide, Pakistan’s first locally manufactured GLP-1 medicine
Ferozsons Laboratories launched Sematide (Semaglutide), Pakistan’s first locally manufactured GLP-1 medicine, representing a landmark achievement in bringing advanced biopharmaceutical innovation to the local healthcare market.
Learn more
2022
Partnership with Nihon Kohden for medical electronic devices
Ferozsons Laboratories established a partnership with Nihon Kohden for the distribution of medical electronic devices, expanding its medical technology portfolio.
Learn more2020
Launch of Remedia (Remdesivir) for COVID-19 treatment
Under its voluntary licensing partnership with Gilead, Ferozsons Laboratories Limited launched Remedia (Remdesivir) in Pakistan for the treatment of severe COVID-19 in hospitalized patients, with the product also exported internationally and used to treat over 100,000 patients worldwide.
Learn more
2017
Partnership with PanTheryx for DiaresQ
Ferozsons Laboratories partnered with PanTheryx Inc., USA, to exclusively market DiaresQ, an innovative nutritional product for childhood diarrhea recognized in the Innovations 2030 Countdown Report by PATH, USAID, and NORAD.
Learn more2016
Agreement with GE Healthcare
Ferozsons Laboratories signed an agreement with GE Healthcare to become a channel partner for the marketing and sale of value-segment medical devices in Pakistan.
Learn more
2014
Partnership with Gilead for Hepatitis C treatment
Ferozsons Laboratories Limited entered into a partnership with Gilead Sciences Inc. to introduce Sovaldi, a breakthrough treatment for Hepatitis C. Pakistan became the first country to implement the access program, enabling thousands of patients to receive the therapy.
Learn more2012
Partnership with BioGaia
Ferozsons Laboratories entered into a partnership with BioGaia to introduce the world’s leading premium Swedish probiotics in Pakistan.
Learn more
2008
Distribution rights for Boston Scientific devices
Ferozsons Laboratories acquired distribution rights for the medical devices of Boston Scientific Inc., USA, a world-leading manufacturer of interventional medical devices.
Learn more2006
Joint venture to establish BF Biosciences
Ferozsons Laboratories signed a joint venture agreement with Bagó Group of Argentina to establish BF Biosciences, marking the creation of Pakistan’s first biopharmaceutical company.
Visit BF Biosciences
2002
Strategic partnerships for oncology and liver disease
Ferozsons Laboratories entered into strategic partnerships with leading international companies, Curatis Pharma GmbH (Germany) and Bagó Group S.A. (Argentina), for the import and marketing of a range of biological products in oncology and liver disease.
Learn more1991
Manufacturing agreement with Procter & Gamble
Entered into a manufacturing agreement with Procter & Gamble Pakistan to produce its flagship brand, Vicks VapoRub®.
Learn more
1964
Preferred pharmaceutical supplier to international organizations
Recognized as a preferred pharmaceutical supplier to foreign missions and major international organizations, including the United Nations, the U.S. Government, and British Crown Agents.
Global collaborations with leading organizations
The Company further strengthened its global presence by establishing collaborations with leading pharmaceutical organizations, including Chemie Grünenthal GmbH of Germany, The Boots Pure Drug Company of the United Kingdom, and Lakeside Laboratories Inc. (Colgate-Palmolive) of the United States.
1961
Expansion into international markets
Expanded exports of high-quality pharmaceutical and chemical products to international markets, including Australia, Hong Kong, Jordan, Singapore, Turkey, and the United Kingdom.
Learn more1960
Listed on Karachi Stock Exchange
In 1960, we became the first Pakistani pharmaceutical company to be listed on the Karachi Stock Exchange (KSE) Limited, and have a consistent track record of delivering on our financial objectives. The company is a multiple-time recipient of the KSE Top 25 Companies Award.
Learn more
1954
Ferozsons Laboratories established
Ferozsons Laboratories Limited was thus established in 1954 as one of the first Pharmaceutical manufacturing companies in Pakistan, and has now entered its seventh decade of serving the cause of health and well-being in Pakistan and a growing number of international markets.
Learn moreOur Commitment.
Learn more about our commitment to advancing patient care and supporting the communities we serve.